2021, Number 4
<< Back
Revista Cubana de Cirugía 2021; 60 (4)
Gastrointestinal stroma tumor in a hospital of Mexico
Moreno GS, Regalado AA, Rivera MJC
Language: Spanish
References: 29
Page: 1-15
PDF size: 446.35 Kb.
ABSTRACT
Introduction:
Gastrointestinal stromal tumors are neoplasms of benign or malignant behavior. They originate from the interstitial cells of Cajal in the digestive tract.
Objective:
The objective of this work is to describe two different forms of clinical presentation.
Case report:
case 1: 65-year-old female patient who presented for compression symptoms of the upper digestive tract due to gastric GIST; case 2: 56-year-old male who presented with bleeding from the middle digestive tract caused by intestinal GIST.
Conclusions:
GISTs have different clinical presentation. Its treatment is essentially surgical and in some cases supplemented with targeted molecular therapy.
REFERENCES
Ahmed M. Recent advances in the management of gastrointestinal stromal tumor. World journal of clinical cases. 2020;8(15):3142-55. DOI: https://doi.org/10.12998/wjcc.v8.i15.3142
Sanchez-Hidalgo JM, Duran-Martínez M, Molero-Payan R, Rufian-Peña S, Arjona-Sanchez A, Casado-Adam A, et al. Gastrointestinal stromal tumors: A multidisciplinary challenge. World journal of gastroenterology. 2018;24(18):1925-41. DOI: https://doi.org/10.3748/wjg.v24.i18.1925
Waidhauser J, Bornemann A, Trepel M, Märkl B. Frequency, localization, and types of gastrointestinal stromal tumor-associated neoplasia. World journal of gastroenterology. 2019;25(30):4261-77. DOI: https://doi.org/10.3748/wjg.v25.i30.4261
Harlan LC, Eisenstein J, Russell MC, Stevens JL, Cardona K. Gastrointestinal stromal tumors: treatment patterns of a population-based sample. J Surg Oncol. 2015;111:702-7.
DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231:51-8.
Pink D, Schoeler D, Lindner T, Thuss-Patience PC, Kretzschmar A, Knipp H, et al. Severe hypoglycemia caused by paraneoplastic production of IGF-II in patients with advanced gastrointestinal stromal tumors: a report of two cases. J Clin Oncol. 2005;23:6809-11.
Maynard MA, Marino-Enríquez A, Fletcher JA, Dorfman DM, Raut CP, Yassa L, et al. Thyroid hormone inactivation in gastrointestinal stromal tumors. The New England journal of medicine. 2014;370(14):1327-34. DOI: https://doi.org/10.1056/NEJMoa1308893
Miettinen M, Fetsch JF, Sobin LH, Lasota J. Tumores del estroma gastrointestinal en pacientes con neurofibromatosis 1: un estudio clínico-patológico y genético molecular de 45 casos. Soy J Surg Pathol. 2006;30:90-6.
Díaz Delgado M, Hernández Amate A, Sánchez León M, Pereira Gallardo S, Prieto Sánchez E, Jiménez Sáenz M, et al. Tumores del estroma gastrointestinal múltiples no metastásicos: Aspectos diferenciales. Revista Española de Enfermedades Digestivas. 2010 [acceso 25/10/2020];102(8):489-97. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082010000800006&lng=es&tlng=es
Janeway KA, Weldon CB. Pediatric gastrointestinal stromal tumor. Semin Pediatr Surg. 2012;21:31-43.
Waidhauser J, Bornemann A, Trepel M, Märkl B. Frequency, localization, and types of gastrointestinal stromal tumor-associated neoplasia. World journal of gastroenterology. 2019;25(30):4261-77. DOI: https://doi.org/10.3748/wjg.v25.i30.4261
Tirumani SH, Baheti AD, Tirumani H, O'Neill A, Jagannathan JP. Update on Gastrointestinal Stromal Tumors for Radiologists. Korean journal of radiology. 2017;18(1):84-93. DOI: https://doi.org/10.3348/kjr.2017.18.1.84
Kamiyama Y, Aihara R, Nakabayashi T, Mochiki E, Asao T, Kuwano H, et al. 18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors. World J Surg. 2005;29:1429-35.
Hassanzadeh-Rad A, Yousefifard M, Katal S, Asady H, Fard-Esfahani A, Moghadas Jafari A, et al. The value of (18) F-fluorodeoxyglucose positron emission tomography for prediction of treatment response in gastrointestinal stromal tumors: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2016;31:929-35.
Kim HH. Endoscopic treatment for gastrointestinal stromal tumor: Advantages and hurdles. World journal of gastrointestinal endoscopy. 2015;7(3):192-205. DOI: https://doi.org/10.4253/wjge.v7.i3.192
Brunaldi VO, Coronel M, Chacon DA, De Moura ET, Matuguma SE, De Moura EG, et al. Subepithelial rectal gastrointestinal stromal tumor - the use of endoscopic ultrasound-guided fine needle aspiration to establish a definitive cytological diagnosis: a case report. Journal of medical case reports. 2017;11(1):59. DOI: https://doi.org/10.1186/s13256-017-1205-7
Eriksson M, Reichardt P, Sundby Hall K, Schütte J, Cameron S, Hohenberger P, et al. Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour - Does it increase the risk for tumour cell seeding and recurrence? Eur J Cancer. 2016;59:128-33.
Feng F, Tian Y, Liu Z, Xu G, Liu S, Guo M, et al. Clinicopathologic Features and Clinical Outcomes of Esophageal Gastrointestinal Stromal Tumor: Evaluation of a Pooled Case Series. Medicine. 2016;95(2):e2446. DOI: https://doi.org/10.1097/MD.0000000000002446
Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol. 2008;39:1411-9.
Everett M, Gutman H. Surgical management of gastrointestinal stromal tumors: analysis of outcome with respect to surgical margins and technique. J Surg Oncol. 2008;98:588-93.
Lanke G, Lee JH. How best to manage gastrointestinal stromal tumor. World journal of clinical oncology. 2017;8(2):135-44. DOI: https://doi.org/10.5306/wjco.v8.i2.135
Koga T, Hirayama Y, Yoshiya S, Taketani K, Nakanoko T, Yoshida R, et al. Necessity for resection of gastric gastrointestinal stromal tumors = 20 mm. Anticancer Res. 2015;35:2341-4.
Dai WJ, Liu G, Wang M, Liu WJ, Song W, Yang XZ, et al. Endoscopic versus laparoscopic resection of gastric gastrointestinal stromal tumors: a multicenter study. Oncotarget. 2017;8(7):11259-67. DOI: https://doi.org/10.18632/oncotarget.13298
Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, et al. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol. 2007;14:14-24.
Bamboat ZM, DeMatteo RP. Metastasectomy for gastrointestinal stromal tumors. Journal of surgical oncology. 2014;109(1):23-7. DOI: https://doi.org/10.1002/jso.23451
Liu P, Tan F, Liu H, Li B, Lei T, Zhao X, et al. The Use of Molecular Subtypes for Precision Therapy of Recurrent and Metastatic Gastrointestinal Stromal Tumor. OncoTargets and therapy. 2020;13:2433-47. DOI: https://doi.org/10.2147/OTT.S241331
Medina Fernández FJ, Muñoz-Casares FC, Arjona-Sánchez A, Casado-Adam A, Rufián Peña S. Gistosis peritoneal: Papel de la cirugía de citorreducción y quimioterapia intraperitoneal perioperatoria. Cir Esp. 2014;92:289-90.
Koo DH, Ryu MH, Kim KM, Yang HK, Sawaki A, Hirota S, et al. Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor. Cancer research and treatment: official journal of Korean Cancer Association. 2016;48(4):1155-66. DOI: https://doi.org/10.4143/crt.2016.187
Qian XH, Yan YC, Gao BQ, Wang WL. Prevalence, diagnosis, and treatment of primary hepatic gastrointestinal stromal tumors. World journal of gastroenterology. 2020;26(40):6195-206. DOI: https://doi.org/10.3748/wjg.v26.i40.6195